Cohance Lifesciences Ltd. benchmarking: Perfomance to industry peers

Financial

	Cohance Lifesciences	Jubilant Pharmova	Syngene Internation.
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	17.0 .	100.0 .	n/a
Unclassified
R&D as a % of Total Sales	4.19 %	0.18 %	n/a
Financials
5 yr Average ROE	22.91 %	7.82 %	12.33 %
5yr average Equity Multiplier	1.35	1.96	1.57
5yr Average Asset Turnover Ratio	0.56	0.61	0.52
5yr Avg Net Profit Margin	30.38 %	6.45 %	15.3 %
Price to Book	20.61	2.84	5.61
P/E	136.62	38.59	52.3
5yr Avg Cash Conversion Cycle	49.95 Days	-39.98 Days	-6453.7 Days
Inventory Days	74.21 Days	74.06 Days	20.52 Days
Days Receivable	63.71 Days	45.59 Days	48.33 Days
Days Payable	80.35 Days	149.89 Days	-264.76 Days
5yr Average Interest Coverage Ratio	49.87	3.78	16.15
5yr Avg ROCE	27.5 %	8.15 %	13.11 %
5yr Avg Operating Profit Margin	40.14 %	16.76 %	29.04 %
5 yr average Debt to Equity	0.06	0.55	0.15
5yr CAGR Net Profit	-5.86 %	0.08 %	4.15 %
5yr Average Return on Assets	17.54 %	4.12 %	7.88 %
Shareholdings
Promoter Holding	66.41 %	47.68 %	52.68 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	6.41 %	-3.0 %	-17.61 %
Change in Mutual Fund Holding (3 Yrs)	2.58 %	5.97 %	17.91 %

Business

	Cohance Lifesciences	Jubilant Pharmova	Syngene Internation.
Product Wise Break-Up	Product Wise Break-Up Contract Technical Services & Formulations 53.77 Contract Research & Contract Manufacturing (CRAMS) 37.04 Specialty Chemicals 9.19 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Discovery Services 0 Dedicated Centres 0 0	Product Wise Break-Up Anti-allergic 9.75 Discovery Services 0 0 Contract Research and Development Services 7.87 Nutritional products 0 Dedicated Centres 0 Active Pharmaceutical Ingredient (API) 7.91 Specialty intermediates 0 Radiopharmaceuticals 46.89 Contract Manufacturing 17.66 Specialty Chemicals 0 Solid dosage formulations 8.71 0 0 India branded pharmaceuticals 0.7 Life science chemicals 0 Others 0.51	Product Wise Break-Up Allergy therapy products 0 Discovery Services 0 0 0 Nutritional products 0 Dedicated Centres 0 Active pharmaceutical ingredients 0 Specialty intermediates 0 Radiopharmaceuticals 0 0 Specialty Chemicals 0 Solid dosage formulations 0 Contract Research & Contract Manufacturing (CRAMS) 96.59 0 India Branded pharmaceuticals 0 Life science chemicals 0 Others 3.41
Location Wise Break-Up	Location Wise Break-Up Europe 64.71 USA 21.74 India 6.4 Rest of the World 0 China 0 Americas and Europe 0 India 0 Europe 0 Japan 0 Others 7.15	Location Wise Break-Up Japan 0 Americas and Europe 91.35 Europe 0 India 2.76 Rest of the World 5.89 China 0 USA 0	Location Wise Break-Up Japan 0 Americas and Europe 0 Europe 32.05 India 1.77 Rest of the World 4.25 China 0 USA 61.93

Cohance Lifesciences Ltd.

Cohance Lifesciences Ltd.

Financial

Business

SIGN UP FOR FREE